Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEFOBAR: Cefoxitin Prophylaxis in Bariatric Surgery
NCT03306290Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cefoxitin in surgical site infection (SSI), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Serum concentration of Cefoxitin. Started Oct 2017; status: completed.
02
Drugs
cefoxitin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03306290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03306290.